BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

971 related articles for article (PubMed ID: 23553777)

  • 21. Targeting of B cells in SLE: rationale and therapeutic opportunities.
    Silverman GJ
    Bull NYU Hosp Jt Dis; 2006; 64(1-2):51-6. PubMed ID: 17121490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenetic aspects of systemic lupus erythematosus with an emphasis on regulatory T cells.
    Scheinecker C; Bonelli M; Smolen JS
    J Autoimmun; 2010 Nov; 35(3):269-75. PubMed ID: 20638240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The busy life of regulatory T cells in systemic lupus erythematosus.
    La Cava A
    Discov Med; 2009 Jun; 8(40):13-7. PubMed ID: 19772836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogenesis of Human Systemic Lupus Erythematosus: A Cellular Perspective.
    Moulton VR; Suarez-Fueyo A; Meidan E; Li H; Mizui M; Tsokos GC
    Trends Mol Med; 2017 Jul; 23(7):615-635. PubMed ID: 28623084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emerging and critical issues in the pathogenesis of lupus.
    Gatto M; Zen M; Ghirardello A; Bettio S; Bassi N; Iaccarino L; Punzi L; Doria A
    Autoimmun Rev; 2013 Feb; 12(4):523-36. PubMed ID: 23000207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mouse models of systemic lupus erythematosus reveal a complex pathogenesis.
    Rottman JB; Willis CR
    Vet Pathol; 2010 Jul; 47(4):664-76. PubMed ID: 20448279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment targets in systemic lupus erythematosus: biology and clinical perspective.
    Marian V; Anolik JH
    Arthritis Res Ther; 2012; 14 Suppl 4(Suppl 4):S3. PubMed ID: 23281796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T follicular helper (Tfh) cells in lupus: Activation and involvement in SLE pathogenesis.
    Blanco P; Ueno H; Schmitt N
    Eur J Immunol; 2016 Feb; 46(2):281-90. PubMed ID: 26614103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New treatments for SLE: cell-depleting and anti-cytokine therapies.
    Anolik JH; Aringer M
    Best Pract Res Clin Rheumatol; 2005 Oct; 19(5):859-78. PubMed ID: 16150407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B-cell tolerance checkpoints in health and autoimmunity.
    Meffre E; Wardemann H
    Curr Opin Immunol; 2008 Dec; 20(6):632-8. PubMed ID: 18848883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. B cells in SLE: different biological drugs for different pathogenic mechanisms.
    Diamanti AP; Rosado MM; Carsetti R; Valesini G
    Autoimmun Rev; 2007 Dec; 7(2):143-8. PubMed ID: 18035325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Innate and adaptive immune pathways to tolerance.
    Thornton CA; Morgan G
    Nestle Nutr Workshop Ser Pediatr Program; 2009; 64():45-57; discussion 57-61, 251-7. PubMed ID: 19710514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B cells participate in tolerance and autoimmunity through cytokine production.
    Luu VP; Vazquez MI; Zlotnik A
    Autoimmunity; 2014 Feb; 47(1):1-12. PubMed ID: 24245950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic lupus erythematosus conundrums.
    Wardle EN
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):731-6. PubMed ID: 19736466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunopathology and the gene therapy of lupus.
    Mageed RA; Prud'homme GJ
    Gene Ther; 2003 May; 10(10):861-74. PubMed ID: 12732872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of innate immunity in autoimmune tissue injury.
    Allam R; Anders HJ
    Curr Opin Rheumatol; 2008 Sep; 20(5):538-44. PubMed ID: 18698174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoimmunity following neonatal tolerance to alloantigens: role of donor I-A and I-E molecules.
    Kramar G; Schurmans S; Berney M; Izui S; del Giudice G; Lambert PH
    J Autoimmun; 1995 Apr; 8(2):177-92. PubMed ID: 7612147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T-regulatory cells in systemic lupus erythematosus.
    La Cava A
    Lupus; 2008 May; 17(5):421-5. PubMed ID: 18490420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peripheral blood lymphocytes in SLE--hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells.
    Devi BS; Van Noordin S; Krausz T; Davies KA
    J Autoimmun; 1998 Oct; 11(5):471-5. PubMed ID: 9802931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in mechanisms of systemic lupus erythematosus.
    Dema B; Charles N
    Discov Med; 2014 May; 17(95):247-55. PubMed ID: 24882716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.